QTERNMET XR

Peak

dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
May 2019
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 12, 2031
63 months away
Patent Expiry
May 12, 2031

Patent Records (5)

Patent #ExpiryTypeUse Code
6515117
Oct 4, 2025Expired
SubstanceProduct
U-493
6515117*PED
Apr 4, 2026
8501698
Jun 20, 2027
Product
U-493
8501698*PED
Dec 20, 2027
8716251
Mar 21, 2028
Product